New principles help organisations to design, review, and secure connectivity to (and within) OT systems.

A Metabolic Disease Posing Severe Pancreatic Risks Gets Its First FDA-Approved Therapy
Ionis Pharmaceuticals’ Tryngolza is now the first approved therapy for treating severe hypertriglyceridemia, a prevalent chronic metabolic disorder that can lead to acute pancreatitis. This


